1- Milach A, de los Santos JRG, Turnes CG, Moreira AN, de Assis RA, Salvarani FM, et al. Production and characterization of Clostridium perfringens recombinant β toxoid. Anaerobe. 2012; 18(3): 363-5.
2- Juneja VK, Marks H, Thippareddi HH. Predictive model for growth of Clostridium perfringens during cooling of cooked ground pork. Innovative food science & emerging technologies. 2010; 11(1): 146-54.
3- Sakurai J, Nagahama M. Clostridium perfringens beta-toxin: characterization and action. Toxin Reviews. 2006; 25(1) :89-108.
4- Bakhshi F, Langroudi RP, Eimani BG. Enhanced expression of recombinant beta toxin of Clostridium perfringens type B using a commercially available Escherichia coli strain. Onderstepoort Journal of Veterinary Research. 2016; 83(1): 1-4.
5- Zayerzadeh E, Fardipour A, Jabbari A. A New Purification Method for Beta-Toxin of Clostridium perfringens Type C Vaccinal Strain. Journal of Medical Bacteriology. 2014; 3(3-4): 8-13.
6- Cavalcanti MTH, Porto T, Porto ALF, Brandi IV, Lima Filho JLd, Pessoa Junior A. Large scale purification of Clostridium perfringens toxins: a review. Revista Brasileira de Ciencias Farmaceuticas. 2004; 40(2): 151-64.
7- Xiong N, Yu R, Chen T, Xue Y-P, Liu Z-Q, Zheng Y-G. Separation and purification of l-methionine from E. coli fermentation broth by macroporous resin chromatography. Journal of Chromatography B. 2019; 1110: 108-15.
8- Coskun O. Separation techniques: chromatography. Northern clinics of Istanbul. 2016;3(2):156.
9- Gagnon P. Technology trends in antibody purification. Journal of chromatography A. 2012; 1221: 57-70.
10- Zhao X, Li G, Liang S. Several affinity tags commonly used in chromatographic purification. Journal of analytical methods in chemistry. 2013; 2013.
11- Fekete S, Beck A, Veuthey J-L, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. Journal of pharmaceutical and biomedical analysis. 2015; 113: 43-55.
12- Schmidt M, Hafner M, Frech C. Modeling of salt and pH gradient elution in ion‐exchange chromatography. Journal of separation science. 2014; 37(1-2): 5-13.
13- Milach A, de los Santos JR, Turnes CG, Moreira AN, de Assis RA, Salvarani FM, et al. Production and characterization of Clostridium perfringens recombinant beta toxoid. Anaerobe. 2012; 18(3): 363-5.
14- Bakhshi F, Langroudi RP, Eimani BGJOJoVR. Enhanced expression of recombinant beta toxin of Clostridium perfringens type B using a commercially available Escherichia coli strain. 2016; 83(1): 1-4.
15- Sayadmanesh A, Ebrahimi F, Hajizade A, Rostamian M, Keshavarz H. Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity. Iranian Biomedical Journal. 2013; 17(4): 165.
16- Fathi Najafi M, Hemmati M, Jabbari AR, Mehrvarz M, Aghaipour K. Purification and characterization of alpha-toxin from vaccinal strain of Clostridium novyi. 2011.
17- Johnson E, Tepp W, Lin G. Purification, characterization, and use of Clostridium botulinum neurotoxin BoNT/A3. Google Patents; 2016.
18- Poursoltani M, Mohsenzadeh M, Razmyar JJIJoMM. Toxinotyping of Clostridium perfringens strains isolated from packed chicken portions. 2014; 8(1): 9-17.
19- Gkogka E, Reij MW, Gorris LG, Zwietering MHJFC. Risk assessment of Clostridium perfringens in Cornish pasties in the UK. 2020; 108: 106822.
20- Nijland R, Lindner C, van Hartskamp M, Hamoen LW, Kuipers OP. Heterologous production and secretion of Clostridium perfringens beta-toxoid in closely related Gram-positive hosts. Journal of biotechnology. 2007; 127(3): 361-72.
21- Bhatia B, Solanki AK, Kaushik H, Dixit A, Garg LCJPe, purification. B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein. 2014; 102: 38-44.
22- Kouguchi H, Watanabe T, Sagane Y, Ohyama TJEJoB. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin. 2001; 268(14): 4019-26.
23- Sakurai J, Duncan CJI, Immunity. Purification of beta-toxin from Clostridium perfringens type C. 1977; 18(3): 741-5.
24- Cavalcanti MTH, Porto T, Porto ALF, Brandi IV, Lima Filho JLd, Pessoa Junior AJRBdCF. Large scale purification of Clostridium perfringens toxins: a review. 2004; 40(2): 151-64.